The risk index as a basis for risk/benefit analyses and protocol optimization in diagnostic nuclear imaging

Author:

Ocampo Ramos Juan C.1,Carter Lukas M.1,Brown Justin L.23,Marquis Harry1,Uribe Carlos F.4,Zanzonico Pat B.1,Bolch Wesley E.2,Kesner Adam L.1

Affiliation:

1. Department of Medical Physics Memorial Sloan Kettering Cancer Center New York New York USA

2. J. Crayton Pruitt Family Department of Biomedical Engineering University of Florida Gainesville Florida USA

3. Department of Diagnostic and Interventional Imaging University of Texas Health Science Center at Houston McGovern Medical School Houston Texas USA

4. Functional Imaging Department BC Cancer Vancouver British Columbia Canada

Abstract

AbstractBackgroundPotential risk associated with low‐dose radiation exposures is often expressed using the effective dose (E) quantity. Other risk‐related quantities have been proposed as alternatives. The recently introduced risk index (RI) shares similarities with E but expands the metric to incorporate medical imaging‐appropriate risks factors including patient‐specific size, age, and sex.PurposeThe aim of this work is to examine the RI metric for quantifying stochastic radiation risk and demonstrate its applications in nuclear imaging. The advantages in this improved metric may help the field progress toward stratified risk consideration in the course of patient management, improve efforts for procedure optimization, and support an evolution in the science of radiation risk assessment.MethodsIn this study we describe, implement, and calculate RI for various diagnostic nuclear imaging scenarios using reference biokinetics published in ICRP Publication 128 for commonly utilized radiopharmaceuticals. All absorbed dose, E and RI calculations were performed using the freely available MIRDcalc nuclear medicine dosimetry software; the organ specific risk parameters used in the software are also benchmarked in this text. The resulting RI and E values are compared and various trends in RI values identified.ResultsE and RI coefficients were calculated for 3016 use cases. Notably RI values vary depending on patient characteristics. Overall, across the population, global trends in RI values can be identified. In general, RI values were 2.15 times higher for females than males, due to higher risk coefficients and activities being distributed in smaller reference masses. The pediatric patients showed higher RIs than adults, as younger patients generally receive higher absorbed doses per administered activity, and are more radiosensitive, and have a longer projected lifespan at risk. A compendium of E and RI values is also provided in table format to serve as a reference for the community.ConclusionsRI is a rational quantity that could be used for justification, risk communication and protocol optimization in medical imaging. It has some advantages when compared to the long‐utilized E value with respect to personalization, since accounts for patient size, age, sex, and natural incidence of cancer risk.

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Medicine

Reference23 articles.

1. Recommendations of the ICRP. ICRP Publication 26;ICRP;Ann ICRP,1977

2. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60;ICRP;Ann ICRP,1991

3. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103;ICRP;Ann ICRP,2007

4. MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature

5. Evolution and evaluation of effective dose in the context of diagnostic nuclear medicine;Ocampo Ramos JC;Eur J Nucl Med Mol Imaging,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3